The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Acalabrutinib with obinutuzumab (Ob) in treatment-naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): Three-year follow-up.
 
Jennifer Ann Woyach
Consulting or Advisory Role - Janssen; Pharmacyclics
Research Funding - Abbvie; Janssen; Karyopharm Therapeutics; Loxo; MorphoSys; Pharmacyclics
 
Kerry Anne Rogers
Consulting or Advisory Role - Acerta Pharma
Research Funding - Abbvie; Genentech
 
Seema Ali Bhat
Speakers' Bureau - Janssen/Pharmacyclics
 
James Stewart Blachly
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Kite, a Gilead company
Patents, Royalties, Other Intellectual Property - Sequencing Technology patent pending (Inst)
Travel, Accommodations, Expenses - Oxford Nanopore Technologies
 
Mojgan Jianfar
No Relationships to Disclose
 
Melanie M. Frigault
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Patents, Royalties, Other Intellectual Property - MET mutation that confers sensitivity to a selective MET inhibitor
Travel, Accommodations, Expenses - AstraZeneca
 
Ahmed M. Hamdy
Employment - Acerta Pharma
Leadership - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
Patents, Royalties, Other Intellectual Property - Acerta Pharma
Travel, Accommodations, Expenses - Acerta Pharma
 
Raquel Izumi
Employment - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
Consulting or Advisory Role - Trigemina
Patents, Royalties, Other Intellectual Property - Patents pending for Acerta Pharma
 
Veerendra Munugalavadla
Employment - Acerta Pharma/AstraZeneca
Stock and Other Ownership Interests - AstraZeneca; Gilead Sciences; Gilead Sciences (I)
Other Relationship - Gilead Sciences (I)
 
Cheng Seok Quah
Employment - Acerta Pharma; Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Min Hui Wang
Employment - Acerta Pharma
Stock and Other Ownership Interests - AstraZeneca; Gilead Sciences
 
John C. Byrd
Consulting or Advisory Role - Acerta Pharma; Genentech; Jazz Pharmaceuticals; Pharmacyclics
Research Funding - Acerta Pharma (Inst); Genentech (Inst); Janssen (Inst); Pharmacyclics (Inst)